MedPath

Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease

Not Applicable
Conditions
Parkinson's Disease
Registration Number
NCT02909192
Lead Sponsor
Massachusetts General Hospital
Brief Summary

Disruption of sleep and alertness is one of the most disabling non-motor symptoms of Parkinson's disease (PD). Mechanisms leading to impaired sleep and alertness in PD are not well understood, and treatment options remain limited. The proposed research will examine markers of the circadian system, sleepiness and sleep quality in PD patients. Further, the project will examine effects of bright light exposure on circadin function, sleep and alertness in PD.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
65
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Parkinson's Disease Sleep Scale (PDSS-2) score to measure sleep quality8 weeks
Secondary Outcome Measures
NameTimeMethod
Epworth Sleepiness Scale (ESS) score to measure daytime sleepiness8 weeks
Plasma melatonin levels collected through blood samples to measure melatonin amplitude and circadian regulation8 weeks
Non-Motor Symptoms Assessment Scale for Parkinson's Disease (NMSS) score to measure the severity and frequency of non-motor symptoms8 weeks

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
Matthew Stauder, B.S.
Contact
617-726-9589
mstauder@mgh.harvard.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.